SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 682.05 |
| Enterprise Value ($M) | 613.67 |
| Book Value ($M) | 11.50 |
| Book Value / Share | 0.25 |
| Price / Book | 59.30 |
| NCAV ($M) | 61.14 |
| NCAV / Share | 1.34 |
| Price / NCAV | 11.16 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.59 |
| Return on Assets (ROA) | -0.58 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.19 |
| Current Ratio | 4.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 85.82 |
| Assets | 92.95 |
| Liabilities | 24.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | |||
| 13G | Vanguard Group Inc | |||
| 13G/A | Highbridge Capital Management Llc | 6.50 | 0.00 | |
| 13G/A | Nippon Shinyaku Co Ltd | 18.90 | 65.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| variable UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 306,244 | 991,165 | 30.90 | |
| 411,389 | 1,167,822 | 35.23 | |
| 211,985 | 709,781 | 29.87 | |
| 401,404 | 1,062,444 | 37.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BTAI – BioXcel Therapeutics, Inc. | BYSI – BeyondSpring Inc. |
| CALC – CalciMedica, Inc. | CARA – Cara Therapeutics, Inc. |
| CASI – CASI Pharmaceuticals, Inc. |